In conclusion, the internal reason for DCHD to regulate glucose and lipid metabolism, reduce insulin resistance and improve islet cell function may be related to inhibiting oxidative stress, regulating inflammatory response, inhibiting islet cell apoptosis, modulating insulin signal transduction, regulating adiponectin and leptin gene expression, and balancing intestinal flora. The gene discussed is ADIPOQ; the disease is Insulin resistance.